UPL Limited UPL
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on UPL
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 13 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Are its options cheap or dear?It compares the movement option prices assume with the movement the share has actually shown.
Live in market hoursImplied volatility needs the live option chain, which is open 9:15 to 3:30.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Pesticides & Agrochemicals · 25 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 2 Nov 2026), sales fell 1.3% from a year earlier to ₹11,860 cr and profit fell 26.1% to ₹452 cr.
- Debt to equity fell 2 years running (0.87 to 0.53).
- Reported a loss in FY24.
- Profit before interest covered interest 2.0 times in FY26 (₹3,401 cr of interest).
- Return on equity stayed under 10% from FY24 to FY26 (highest 5.6%).
- Foreign institutions raised their holding by 5.9 points over 5 quarters (37.82% to 43.67%).
- Domestic institutions cut their holding by 3.8 points over 5 quarters (18.10% to 14.31%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
How the share moved on resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 8 and fell on 12, and moved by 3% or more on 12.
Q2 FY27: results filed 2 Nov 2026. The share went from its close on 30 Oct 2026 to its close on 3 Nov 2026 +0.88%.
Dividends paidCash the company has paid per share, year by year.
2026 has paid ₹6.00 per share, about ₹1,073 on ₹1 lakh at today's price. Earlier years are restated to today's share count, so a bonus or split never reads as a dividend cut. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 20 years this compounded at +9.4% a year. The last twelve months were down -26.2%. Price only, before dividends.
Who owns itThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Shareholding patternEach line is that holder's share of all shares over the last 7 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.
Last 18 monthsRecent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsAt a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Pesticides & Agrochemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
The business, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹4.3 as profit. Other income added ₹1.3.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearWhere the cash wentProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
From the cash flow statementIn FY26 cash fell by ₹3,503 Cr, after ₹1,666 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | 15.9% | -19.6% | 8.2% | 11.2% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 19.0% | 10.5% | 16.3% | 17.9% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 8.2% | -4.4% | 1.8% | 4.3% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 12.5% | -5.5% | 2.3% | 5.6% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 13.6% | 3.4% | 8.0% | 10.8% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.65x | 0.87x | 0.63x | 0.53x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 2.7x | 0.5x | 1.4x | 2.0x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Pesticides & Agrochemicals| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| UPL UPL Limited | 47,223 cr | 26.0x | 1.4x | 5.6% | 10.8% | 0.79 | 4.1% | -1.3% | 1.07% |
| PIIND PI Industries Limited | 26,017 cr | 29.6x | 2.3x | 12.3% | 15.7% | 0.02 | 13.8% | -9.1% | 0.87% |
| SUMICHEM Sumitomo Chemical India Limited | 17,300 cr | 31.0x | 4.7x | 17.2% | 23.3% | 0.00 | 17.4% | -2.4% | 0.38% |
| BAYERCROP Bayer Cropscience Limited | 15,492 cr | 20.8x | - | - | - | - | 14.1% | -19.5% | 6.96% |
| SHARDACROP Sharda Cropchem Limited | 6,591 cr | 10.2x | 2.0x | 21.7% | 27.3% | 0.00 | 11.8% | +13.2% | 2.05% |
| DHANUKA Dhanuka Agritech Limited | 4,047 cr | 14.4x | 2.3x | 18.6% | 24.4% | 0.00 | 14.1% | +9.9% | 0.22% |
| RALLIS Rallis India Limited | 3,680 cr | 18.7x | 1.7x | 9.3% | 12.9% | 0.00 | 6.7% | -0.3% | 1.59% |
| NACLIND NACL Industries Limited | 2,771 cr | 369.7x | 3.9x | 0.8% | 6.2% | 0.51 | 0.6% | -18.1% | 0.00% |
| BHAGCHEM Bhagiradha Chemicals & Industries Limited | 2,438 cr | 88.7x | 3.4x | 2.6% | 4.5% | 0.51 | 4.3% | +21.3% | 0.08% |
| GSPCROP GSP Crop Science Limited | 2,041 cr | 23.1x | 2.5x | 12.3% | 15.9% | 0.34 | 5.2% | - | 0.23% |
| BHARATRAS Bharat Rasayan Limited | 1,750 cr | 12.8x | 1.3x | 12.1% | 15.7% | 0.04 | 10.8% | +23.4% | 0.05% |
| INSECTICID Insecticides (India) Limited | 1,571 cr | 12.9x | 1.2x | 12.1% | 15.9% | 0.18 | 5.8% | +7.6% | 1.30% |
| MOL Meghmani Organics Limited | 1,412 cr | 16.3x | 0.9x | 1.9% | 6.7% | 0.41 | 4.0% | +15.5% | 0.00% |
| IPL India Pesticides Limited | 1,370 cr | 14.5x | 1.3x | 11.9% | 15.5% | 0.08 | 9.7% | -21.2% | 0.63% |
| ASTEC Astec LifeSciences Limited | 1,230 cr | - | 3.7x | -25.8% | -5.7% | 0.99 | -18.1% | -2.3% | 0.00% |
| PUNJABCHEM Punjab Chemicals & Crop Protection Limited | 1,118 cr | 18.5x | 2.5x | 16.2% | 18.2% | 0.65 | 5.3% | +28.0% | 0.33% |
| DHARMAJ Dharmaj Crop Guard Limited | 807 cr | 14.4x | 1.6x | 13.0% | 16.4% | 0.24 | 4.9% | -4.2% | 0.00% |
| ADVANCE Advance Agrolife Limited | 796 cr | 18.1x | 2.3x | 11.4% | 13.9% | 0.32 | 5.1% | +35.0% | 0.00% |
| HERANBA Heranba Industries Limited | 602 cr | - | 0.8x | -9.6% | -1.6% | 0.60 | -5.2% | -28.7% | 0.00% |
| BESTAGRO Best Agrolife Limited | 538 cr | 11.2x | 0.6x | 1.2% | 5.2% | 0.53 | 4.1% | -21.2% | 0.66% |
| SHIVALIK Shivalik Rasayan Limited | 481 cr | 33.8x | 0.8x | 3.2% | 4.6% | 0.17 | 5.4% | +7.2% | 0.16% |
| IGCL Indogulf Cropsciences Limited | 390 cr | 8.0x | 0.8x | 10.9% | 12.3% | 0.43 | 6.3% | +3.0% | 0.00% |
| SIKKO Sikko Industries Limited | 224 cr | 36.6x | 2.4x | 6.1% | 7.8% | 0.07 | 9.4% | +21.3% | 0.00% |
| CLSL Crop Life Science Limited | 162 cr | - | - | - | - | - | - | - | 0.00% |
| ARISTO Aristo Bio-Tech And Lifescience Limited | 80 cr | 11.2x | 1.8x | - | 19.5% | 0.80 | 2.0% | +3.2% | 0.51% |
| DHANSA Dhansa Labs Limited | 61 cr | 10.2x | 0.7x | - | 8.4% | 0.48 | 3.9% | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Month by monthThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Price return each month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.5 | -9.4 | -10.9 | +13.0 | +0.5 | -11.4 | +5.7 | -7.0 | -4.0 | -4.9 | +9.0 | · | -29.6% 11m |
| 2025 | +20.5 | +4.8 | +0.5 | +5.3 | -6.3 | +5.3 | +6.4 | +1.7 | -8.4 | +9.8 | +5.3 | +4.8 | +58.7% |
| 2024 | -8.4 | -12.7 | -2.9 | +11.2 | +0.3 | +12.2 | +0.2 | +4.6 | +2.5 | -9.7 | +2.6 | -8.1 | -11.1% |
| 2023 | +5.7 | -8.3 | +3.4 | +3.2 | -7.5 | +0.4 | -9.1 | -5.4 | +4.3 | -12.3 | +5.6 | +2.9 | -18.0% |
| 2022 | +3.9 | -14.3 | +15.7 | +6.9 | -5.3 | -18.9 | +17.2 | +3.8 | -12.6 | +8.7 | +8.2 | -9.3 | -4.1% |
| 2021 | +20.2 | +0.2 | +14.3 | -5.5 | +34.3 | -2.7 | +2.0 | -8.3 | -4.5 | +4.6 | -7.9 | +9.6 | +60.2% |
| 2020 | -9.9 | -1.3 | -37.2 | +28.6 | -3.4 | +4.8 | +12.4 | +5.8 | -0.6 | -9.9 | -7.8 | +11.7 | -20.2% |
| 2019 | +3.7 | +11.6 | +9.3 | +1.1 | +3.1 | -6.2 | -4.8 | -5.4 | +7.2 | -1.2 | -3.9 | +2.0 | +15.6% |
| 2018 | -1.4 | -3.1 | +0.2 | -0.1 | -3.0 | -12.6 | +4.1 | +11.1 | -7.1 | +1.5 | +12.4 | +0.1 | -0.6% |
| 2017 | +12.0 | -0.9 | +1.2 | +10.9 | +6.8 | -2.4 | +4.4 | -5.6 | -6.0 | +2.7 | -8.5 | +4.3 | +17.9% |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2025-08-26 | UNIPHOS ENTERPRISES LTD · block | SELL | 9,80,000 | ₹723.05 | ₹70.86 Cr |
| 2025-08-26 | NERKA CHEMICALS PRIVATE LTD · block | BUY | 9,80,000 | ₹723.05 | ₹70.86 Cr |
| 2025-02-10 | UNIPHOS ENTERPRISES LTD · block | SELL | 7,80,000 | ₹641.00 | ₹50.00 Cr |
| 2025-02-10 | NERKA CHEMICALS PRIVATE LTD · block | BUY | 7,80,000 | ₹641.00 | ₹50.00 Cr |
| 2024-12-27 | UNIPHOS ENTERPRISES LTD · block | SELL | 10,00,000 | ₹504.00 | ₹50.40 Cr |
| 2024-12-27 | NERKA CHEMICALS PRIVATE LTD · block | BUY | 10,00,000 | ₹504.00 | ₹50.40 Cr |
| 2022-11-14 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 7,98,693 | ₹767.90 | ₹61.33 Cr |
| 2022-11-14 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 7,98,693 | ₹767.90 | ₹61.33 Cr |
- Press releasePress Release2 Nov 2026
UPL Limited has informed the Exchange regarding "Press release dated November 2, 2026, titled "Unaudited Financial Results for Q2 and H1 FY 2027"
- Board outcomeOutcome of Board Meeting2 Nov 2026
UPL Limited has submitted to the Exchange, the Unaudited Consolidated and Standalone financial results for the quarter and half year ended September 30, 2026.
- Press releasePress Release3 Aug 2026
UPL Limited has informed the Exchange regarding "Press release dated August 3, 2026, titled "Unaudited Financial Results for Q1 FY 2027".
- Board outcomeOutcome of Board Meeting3 Aug 2026
UPL Limited has submitted to the Exchange about Board Meeting Outcome for Unaudited Consolidated and Standalone Financial Results for the Quarter Ended June 30, 2026.
- Press releasePress Release11 May 2026
UPL Limited has informed the Exchange regarding a press release dated May 11, 2026, titled "Audited Financial Results for the financial year ended March 31, 2026".
- Board outcomeOutcome of Board Meeting11 May 2026
UPL Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Press releasePress Release2 Feb 2026
UPL Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Unaudited Financial Results for Q3 and 9M FY 2026".
- Board outcomeOutcome of Board Meeting2 Feb 2026
UPL Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Press releasePress Release6 Nov 2025
UPL Limited has informed the Exchange regarding a press release dated November 06, 2025, titled "Unaudited Financial Results for Q2 and H1 FY 2026".
- Board outcomeOutcome of Board Meeting6 Nov 2025
UPL Limited has submitted to the Exchange, the Unaudited Consolidated and Standalone financial results for the quarter and half year ended September 30, 2025.
- Press releasePress Release1 Aug 2025
UPL Limited has informed the Exchange regarding a press release dated August 1, 2025, titled Q1 FY26 Financial Results.
- Board outcomeOutcome of Board Meeting1 Aug 2025
UPL Limited has submitted to the Exchange, the Unaudited Consolidated and Standalone financial results for the quarter ended June 30, 2025.
- Integrated Filing- Financial31 Jan 2025
Integrated Filing (Financial) for the quarter and nine months ended 31st December,2024
- Financial Result Updates31 Jan 2025
UPL Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test UPL. “Buy UPL when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free